首页> 外文期刊>Diabetes research and clinical practice >B-RCA revealed circulating miR-33a/b associates with serum cholesterol in type 2 diabetes patients at high risk of ASCVD
【24h】

B-RCA revealed circulating miR-33a/b associates with serum cholesterol in type 2 diabetes patients at high risk of ASCVD

机译:B-RCA透露循环miR-33a / b与血清胆固醇的血清胆固醇患者,患有2型糖尿病患者的高风险患者

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: Type 2 diabetes (T2D) is a complex metabolic disease with high incidence throughout the world. Dyslipidemia is the leading cause of atherosclerotic cardiovascular diseases (ASCVD) in T2D patients hsa-miR-33 (miR-33) serves as a regulator in lipid metabolism. We hypothesized that blood miR-33 associates with serum lipids in T2D patients at high risk of ASCVD events.
机译:目的:2型糖尿病(T2D)是一种复杂的代谢疾病,其全世界具有高发病率。 血脂血症是T2D患者HSA-MIR-33(MIR-33)中动脉粥样硬化心血管疾病(ASCVD)的主要原因用作脂质代谢的调节剂。 我们假设血液miR-33在T2D患者中与血清脂质在高风险的患者中涉及ASCVD事件的高风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号